Dr. Ketevan Berekashvili, MD

Dr. Berekashvili practices at Wynn Hospital in Utica, New York, part of Mohawk Valley Health System.

Dr. Berekashvili's NPI, 1114284734, was assigned on April 20, 2012. Dr. Berekashvili holds New York license 286750.

Dr. Berekashvili's primary practice is Wynn Hospital, at 1656 Champlin Avenue, Utica, NY 13503 in Oneida County. The practice phone is (315) 624-6002.

Dr. Berekashvili's primary practice is Wynn Hospital in Utica, New York, part of Mohawk Valley Health System. Dr. Berekashvili is also affiliated with NYC Health + Hospitals/South Brooklyn Health, Ruth Bader Ginsburg Hospital. The medical group on file is Mohawk Valley Health System. Dmand AI also links Dr. Berekashvili to 3 more group practices and clinics and 3 medical groups, each named with a free account. Dr. Berekashvili's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Berekashvili practices, 5 sites in all. Vendor and product names are available with a free account.

Vascular neurology is Dr. Berekashvili's primary specialty in the NPI Registry, under taxonomy code 2084V0102X. Dr. Berekashvili is licensed in New York.

CMS data shows 38 Medicare services from Dr. Berekashvili across 2 procedure codes in 2022, for 35 Medicare patients. Medicare paid $12,051 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 35 Medicare patients who saw Dr. Berekashvili in 2024. The largest group is 65 to 74, with 16 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 34% are also on Medicaid. Their average risk score is 1.46, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Berekashvili's median patient age at 75, with 49% women.

In 2024, Dr. Berekashvili wrote 18 Medicare Part D claims. 100% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $51 in total drug cost. In 2023, CMS named 14 claims across 1 drug.

Dr. Berekashvili accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 9 papers to Dr. Berekashvili, published from 2015 to 2025. The most frequent topics are Fibrinolytic Agents, Stroke and Endovascular Procedures. Dr. Berekashvili has published most often in J Stroke Cerebrovasc Dis. Dr. Berekashvili's most frequent co-authors are Mohammad El-Ghanem, MD, James C. Grotta, MD and Matthew David Sanger, MD.

CMS Open Payments shows 68 general payments to Dr. Berekashvili from 20 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 61% of the total. Stryker Corporation paid the most, $1,865.